Author
Peng Xu
- Indexed works
- 7
- Total citations
- 549
- Active years
- 3
Collaborators
Works in the record
Nature Medicine 2023
Preprint · OA
Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial
Nature Cell Biology 2023
Preprint · OA
Autophagy enables microglia to engage amyloid plaques and prevents microglial senescence
Research Square 2023
Preprint · CC-BY
Senolytic therapy to modulate the progression of Alzheimer’s Disease (SToMP-AD) – Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease
Neurotherapeutics 2025
Open access · CC-BY
Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer’s disease
Antioxidants 2024
Open access · CC-BY
Anoectochilus roxburghii Extract Extends the Lifespan of Caenorhabditis elegans through Activating the daf-16/FoxO Pathway
Research Square 2024
Preprint · CC-BY
Evaluation of Exploratory Fluid Biomarker Results from a Phase 1 Senolytic Trial in Mild Alzheimer’s Disease
Journal of Cellular Physiology 2025
Citation only